United Polyfab Gujarat Ltd: Intrinsic Value & Share Price Analysis

Last Updated: January 2, 2026, 8:44 pm

All Competitor Stocks of United Polyfab Gujarat Ltd

Last Updated: December 28, 2025, 5:03 pm

Below is a detailed analysis of the quarterly data for United Polyfab Gujarat Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Sales, as of Sep 2025, the value is 185.22 Cr.. The value appears strong and on an upward trend. It has increased from 146.18 Cr. (Jun 2025) to 185.22 Cr., marking an increase of 39.04 Cr..
• For Expenses, as of Sep 2025, the value is 172.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 132.82 Cr. (Jun 2025) to 172.55 Cr., marking an increase of 39.73 Cr..
• For Operating Profit, as of Sep 2025, the value is 12.67 Cr.. The value appears to be declining and may need further review. It has decreased from 13.36 Cr. (Jun 2025) to 12.67 Cr., marking a decrease of 0.69 Cr..
• For OPM %, as of Sep 2025, the value is 6.84%. The value appears to be declining and may need further review. It has decreased from 9.14% (Jun 2025) to 6.84%, marking a decrease of 2.30%.
• For Other Income, as of Sep 2025, the value is 3.78 Cr.. The value appears strong and on an upward trend. It has increased from 0.43 Cr. (Jun 2025) to 3.78 Cr., marking an increase of 3.35 Cr..
• For Interest, as of Sep 2025, the value is 2.71 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.40 Cr. (Jun 2025) to 2.71 Cr., marking an increase of 0.31 Cr..
• For Depreciation, as of Sep 2025, the value is 3.40 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.40 Cr..
• For Profit before tax, as of Sep 2025, the value is 10.34 Cr.. The value appears strong and on an upward trend. It has increased from 7.99 Cr. (Jun 2025) to 10.34 Cr., marking an increase of 2.35 Cr..
• For Tax %, as of Sep 2025, the value is 26.40%. The value appears to be increasing, which may not be favorable. It has increased from 25.78% (Jun 2025) to 26.40%, marking an increase of 0.62%.
• For Net Profit, as of Sep 2025, the value is 7.60 Cr.. The value appears strong and on an upward trend. It has increased from 5.93 Cr. (Jun 2025) to 7.60 Cr., marking an increase of 1.67 Cr..
• For EPS in Rs, as of Sep 2025, the value is 0.33. The value appears strong and on an upward trend. It has increased from 0.26 (Jun 2025) to 0.33, marking an increase of 0.07.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 4:27 am

Last Updated: September 5, 2025, 1:50 pm

Last Updated: December 10, 2025, 3:36 am

Below is a detailed analysis of the balance sheet data for United Polyfab Gujarat Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
• For Reserves, as of Sep 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 25.00 Cr..
• For Borrowings, as of Sep 2025, the value is 109.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 118.00 Cr. (Mar 2025) to 109.00 Cr., marking a decrease of 9.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 39.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Mar 2025) to 39.00 Cr., marking an increase of 9.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 270.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 246.00 Cr. (Mar 2025) to 270.00 Cr., marking an increase of 24.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 87.00 Cr.. The value appears to be declining and may need further review. It has decreased from 94.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 7.00 Cr..
• For CWIP, as of Sep 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 8.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 175.00 Cr.. The value appears strong and on an upward trend. It has increased from 152.00 Cr. (Mar 2025) to 175.00 Cr., marking an increase of 23.00 Cr..
• For Total Assets, as of Sep 2025, the value is 270.00 Cr.. The value appears strong and on an upward trend. It has increased from 246.00 Cr. (Mar 2025) to 270.00 Cr., marking an increase of 24.00 Cr..

However, the Borrowings (109.00 Cr.) are higher than the Reserves (99.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for United Polyfab Gujarat Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 3.09 (Mar 24) to 7.71, marking an increase of 4.62.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 3.09 (Mar 24) to 7.71, marking an increase of 4.62.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.37. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 13.37, marking an increase of 4.91.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.40. It has increased from 34.70 (Mar 24) to 42.40, marking an increase of 7.70.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 42.40. It has increased from 34.70 (Mar 24) to 42.40, marking an increase of 7.70.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 262.38. It has decreased from 395.82 (Mar 24) to 262.38, marking a decrease of 133.44.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 19.13. This value is within the healthy range. It has increased from 14.88 (Mar 24) to 19.13, marking an increase of 4.25.
• For PBIT / Share (Rs.), as of Mar 25, the value is 13.47. This value is within the healthy range. It has increased from 9.30 (Mar 24) to 13.47, marking an increase of 4.17.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.26. This value is within the healthy range. It has increased from 5.36 (Mar 24) to 9.26, marking an increase of 3.90.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 2.88 (Mar 24) to 7.71, marking an increase of 4.83.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 2.88 (Mar 24) to 7.71, marking an increase of 4.83.
• For PBDIT Margin (%), as of Mar 25, the value is 7.29. This value is below the healthy minimum of 10. It has increased from 3.75 (Mar 24) to 7.29, marking an increase of 3.54.
• For PBIT Margin (%), as of Mar 25, the value is 5.13. This value is below the healthy minimum of 10. It has increased from 2.34 (Mar 24) to 5.13, marking an increase of 2.79.
• For PBT Margin (%), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 10. It has increased from 1.35 (Mar 24) to 3.52, marking an increase of 2.17.
• For Net Profit Margin (%), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 5. It has increased from 0.72 (Mar 24) to 2.93, marking an increase of 2.21.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 8. It has increased from 0.72 (Mar 24) to 2.93, marking an increase of 2.21.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.17. This value is within the healthy range. It has increased from 8.29 (Mar 24) to 18.17, marking an increase of 9.88.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.16. This value is within the healthy range. It has increased from 13.45 (Mar 24) to 20.16, marking an increase of 6.71.
• For Return On Assets (%), as of Mar 25, the value is 7.18. This value is within the healthy range. It has increased from 2.72 (Mar 24) to 7.18, marking an increase of 4.46.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.50. This value is within the healthy range. It has decreased from 0.88 (Mar 24) to 0.50, marking a decrease of 0.38.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.58 (Mar 24) to 1.22, marking a decrease of 0.36.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.46. It has increased from 0.00 (Mar 24) to 2.46, marking an increase of 2.46.
• For Current Ratio (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.63, marking a decrease of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.16, marking a decrease of 0.18.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 17.18. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 17.18, marking an increase of 17.18.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.54. This value is within the healthy range. It has increased from 3.78 (Mar 24) to 4.54, marking an increase of 0.76.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.83. This value is below the healthy minimum of 3. It has increased from 1.73 (Mar 24) to 2.83, marking an increase of 1.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 456.59. It has increased from 330.67 (Mar 24) to 456.59, marking an increase of 125.92.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 24) to 0.75, marking an increase of 0.39.
• For EV / EBITDA (X), as of Mar 25, the value is 10.40. This value is within the healthy range. It has increased from 9.68 (Mar 24) to 10.40, marking an increase of 0.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.56, marking an increase of 0.33.
• For Price / BV (X), as of Mar 25, the value is 3.53. This value exceeds the healthy maximum of 3. It has increased from 2.64 (Mar 24) to 3.53, marking an increase of 0.89.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.56, marking an increase of 0.33.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis